MedTrace Logo

Clinical Trial of Anusol Ointment for Symptom Relief in Patients With Haemorrhoids

NCT05157711 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2022-08-15

No results posted yet for this study

Summary

The purpose of this study is to assess the efficacy and safety of Anusol topical ointment for the relief of internal and external haemorrhoid symptoms in people with Grades I-III haemorrhoids compared to a placebo (the study medication without the active ingredients) and a benchmark product.

Conditions

Interventions

DRUG

Anusol

Daily at night and in the morning and after each bowel movement for two weeks

DRUG

Relief [Name]

Daily at night and in the morning and after each bowel movement for two weeks

DRUG

Placebo

Daily at night and in the morning and after each bowel movement for two weeks

Sponsors & Collaborators

  • Church & Dwight Company, Inc.

    lead INDUSTRY

Principal Investigators

  • Annahita Ghassemi, PhD · Director, Global Product Safety & Clinical Affairs Church & Dwight Co., Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-25
Primary Completion
2022-03-31
Completion
2022-03-31

Countries

  • Armenia

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05157711 on ClinicalTrials.gov